The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings and University Subject Rankings. Click here for individual or institutional registration.
Only in AD Scientific Index !!!!
Subject Rankings, University Subject Rankings, Citiation Rankings, i10 Productivity Rankings, Country Rankings, Detailed analyses of universities
AD Scientific Index - World Scientists Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
1 | 5,480 | 5,985 | 12,009 |
|
United States | Pfizer Inc. |
Others
rare disease | gene therapy | |
91 | 41 | 0.451 | 287 | 162 | 0.564 | 32,624 | 7,527 | 0.231 |
2 | 11,381 | 12,535 | 26,395 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Biostatistics
health measurement scales | meta-analysis | |
72 | 47 | 0.653 | 276 | 186 | 0.674 | 31,612 | 11,208 | 0.355 |
3 | 13,692 | 15,151 | 32,394 |
|
United States | Pfizer Inc. |
Others
in vitro toxicology | predictive tox | developmental and reproductive toxicology | |
68 | 27 | 0.397 | 164 | 74 | 0.451 | 13,954 | 2,673 | 0.192 |
4 | 16,291 | 18,071 | 39,378 |
|
United States | Pfizer Inc. |
Natural Sciences / Biological Science
vaccines | virology | structural biology | |
63 | 50 | 0.794 | 109 | 90 | 0.826 | 38,534 | 33,050 | 0.858 |
5 | 17,017 | 18,898 | 41,354 |
|
United States | Pfizer Inc. |
Engineering & Technology / Computer Science
Data Science | Machine Learning | Drug Development | Clinical Trials | Medical Informatics | |
62 | 48 | 0.774 | 162 | 136 | 0.840 | 17,519 | 10,124 | 0.578 |
6 | 17,200 | 19,107 | 41,946 |
|
United States | Pfizer Inc. |
Others
|
62 | 40 | 0.645 | 161 | 110 | 0.683 | 19,075 | 7,304 | 0.383 |
7 | 17,333 | 19,257 | 42,317 |
|
United States | Pfizer Inc. |
Others
powder compaction flow segregation computational modeling | |
62 | 36 | 0.581 | 132 | 101 | 0.765 | 20,512 | 5,304 | 0.259 |
8 | 18,969 | 21,101 | 46,696 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
drug metabolism | clinical pharmacology | phamacometrics | |
60 | 34 | 0.567 | 306 | 146 | 0.477 | 18,443 | 8,241 | 0.447 |
9 | 29,070 | 32,614 | 76,520 |
|
United States | Pfizer Inc. |
Engineering & Technology / Computer Science
Data management. Data integration and visualization. Platform development. Software Solution Development. | |
50 | 32 | 0.640 | 163 | 70 | 0.429 | 20,708 | 7,035 | 0.340 |
10 | 29,944 | 33,615 | 79,179 |
|
United States | Pfizer Inc. |
Natural Sciences / Molecular Biology & Genetics
computational toxicology | bioinformatics | computational biology | toxicology | genomics | |
49 | 40 | 0.816 | 69 | 62 | 0.899 | 11,030 | 5,358 | 0.486 |
Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages |
||||||||||||||||
11 | 30,210 | 33,914 | 80,190 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Pfizer Global R&D | |
49 | 34 | 0.694 | 111 | 95 | 0.856 | 7,775 | 3,734 | 0.480 |
12 | 30,804 | 34,602 | 82,069 |
|
United States | Pfizer Inc. |
Natural Sciences / Molecular Biology & Genetics
Genetic Epidemiology | COPD | Parkinson disease | |
49 | 25 | 0.510 | 74 | 46 | 0.622 | 8,959 | 2,312 | 0.258 |
13 | 31,907 | 35,860 | 85,554 |
|
United States | Pfizer Inc. |
Natural Sciences / Biological Science
Protein engineering | Antibodies | Structural Biology | Immunology | Biochemistry | |
48 | 29 | 0.604 | 94 | 66 | 0.702 | 7,718 | 2,313 | 0.300 |
14 | 32,134 | 36,123 | 86,223 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Microbiology
Microbiology | Infectious Disease Research | |
48 | 26 | 0.542 | 68 | 49 | 0.721 | 8,020 | 1,807 | 0.225 |
15 | 33,424 | 37,581 | 90,430 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Endocrinology and Metabolism
Toxicology | Molecular Toxicology | Endocrinology | microRNA | |
47 | 27 | 0.574 | 134 | 68 | 0.507 | 7,953 | 2,456 | 0.309 |
16 | 33,757 | 37,957 | 91,391 |
|
United States | Pfizer Inc. |
Others
|
47 | 22 | 0.468 | 91 | 48 | 0.527 | 6,688 | 1,652 | 0.247 |
17 | 35,119 | 39,492 | 95,832 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Dermatology and Venereology
Dermatology | Immunology | Oncology | |
46 | 25 | 0.543 | 76 | 47 | 0.618 | 7,920 | 2,289 | 0.289 |
18 | 38,319 | 43,183 | 106,239 |
|
United States | Pfizer Inc. |
Natural Sciences / Biological Science
Drug Discovery | Structural Biology | |
44 | 25 | 0.568 | 63 | 40 | 0.635 | 8,199 | 2,311 | 0.282 |
19 | 42,153 | 47,546 | 118,851 |
|
United States | Pfizer Inc. |
Natural Sciences / Molecular Biology & Genetics
Computational biology | oncology | computational chemistry | |
42 | 22 | 0.524 | 68 | 33 | 0.485 | 7,572 | 2,494 | 0.329 |
20 | 43,548 | 49,139 | 123,689 |
|
United States | Pfizer Inc. |
Social Sciences / Transportation Science & Technology
Transporters | DDI | Absorption | Pharmacokinetics | |
41 | 27 | 0.659 | 62 | 47 | 0.758 | 5,578 | 2,184 | 0.392 |
21 | 45,428 | 51,293 | 130,121 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Internal Medicine
Computational Biology | protein structure | evolution | GWAS | |
40 | 28 | 0.700 | 59 | 41 | 0.695 | 9,023 | 4,093 | 0.454 |
22 | 47,128 | 53,211 | 135,800 |
|
United States | Pfizer Inc. |
Others
vaccines | infectious diseases | clinical trials | epidemiology | |
39 | 31 | 0.795 | 81 | 69 | 0.852 | 7,412 | 5,539 | 0.747 |
23 | 48,121 | 54,372 | 139,408 |
|
United States | Pfizer Inc. |
Others
Drug Development | Positron Emission Tomography | Biomarkers | Imaging | Digital Medicine | |
39 | 23 | 0.590 | 95 | 49 | 0.516 | 5,154 | 1,794 | 0.348 |
24 | 48,266 | 54,540 | 139,911 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Medicinal Chemistry | |
39 | 22 | 0.564 | 76 | 35 | 0.461 | 4,941 | 2,069 | 0.419 |
25 | 48,692 | 55,020 | 141,164 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Neuroscience
Neuroscience | |
39 | 17 | 0.436 | 58 | 24 | 0.414 | 3,911 | 791 | 0.202 |
26 | 49,715 | 56,169 | 144,875 |
|
United States | Pfizer Inc. |
Natural Sciences / Biological Science
structural biology | |
38 | 28 | 0.737 | 62 | 53 | 0.855 | 5,626 | 2,849 | 0.506 |
27 | 50,491 | 57,046 | 147,748 |
|
United States | Pfizer Inc. |
Engineering & Technology / Metallurgical & Materials Engineering
NMR | Materials science | BioPharma | |
38 | 22 | 0.579 | 71 | 36 | 0.507 | 6,087 | 2,166 | 0.356 |
28 | 50,551 | 57,111 | 147,861 |
|
United States | Pfizer Inc. |
Others
|
38 | 22 | 0.579 | 54 | 36 | 0.667 | 7,998 | 1,578 | 0.197 |
29 | 50,881 | 57,479 | 148,999 |
|
United States | Pfizer Inc. |
Others
pneumococcal vaccines | |
38 | 18 | 0.474 | 78 | 25 | 0.321 | 5,578 | 1,532 | 0.275 |
30 | 52,178 | 58,942 | 153,757 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Health Sciences
patient preference | |
37 | 26 | 0.703 | 99 | 70 | 0.707 | 7,622 | 4,295 | 0.564 |
A New and Different Feature!!!! University Subject Rankings in 12 subjects:Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc. |
||||||||||||||||
31 | 52,621 | 59,461 | 155,406 |
|
United States | Pfizer Inc. |
Natural Sciences / Biological Science
Structure-based drug design | structural biology | protein crystallography | |
37 | 24 | 0.649 | 55 | 45 | 0.818 | 5,453 | 1,512 | 0.277 |
32 | 52,764 | 59,626 | 155,914 |
|
United States | Pfizer Inc. |
Natural Sciences / Molecular Biology & Genetics
Computational Biology | |
37 | 23 | 0.622 | 55 | 40 | 0.727 | 4,824 | 1,524 | 0.316 |
33 | 55,127 | 62,326 | 164,266 |
|
United States | Pfizer Inc. |
Others
Drug Discovery | DMPK | Quantitative Systems Pharmacology | PBPK | Data Science | |
36 | 24 | 0.667 | 61 | 44 | 0.721 | 4,366 | 1,836 | 0.421 |
34 | 55,227 | 62,443 | 164,712 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / General Surgery
Surgery | Combination Products | Medical devices | Image-Guided Interventions | Robotics | |
36 | 23 | 0.639 | 73 | 44 | 0.603 | 5,763 | 3,397 | 0.589 |
35 | 55,433 | 62,682 | 165,433 |
|
United States | Pfizer Inc. |
Others
bioanalysis of biotherapeutics | immunogenicity of biotherapeutics | |
36 | 22 | 0.611 | 60 | 42 | 0.700 | 3,953 | 1,758 | 0.445 |
36 | 55,471 | 62,721 | 165,527 |
|
United States | Pfizer Inc. |
Others
Drug Discovery | |
36 | 22 | 0.611 | 49 | 36 | 0.735 | 5,795 | 2,635 | 0.455 |
37 | 57,956 | 65,536 | 174,468 |
|
United States | Pfizer Inc. |
Natural Sciences / Molecular Biology & Genetics
bioinformatics | biostatistics | |
35 | 23 | 0.657 | 45 | 33 | 0.733 | 13,997 | 3,787 | 0.271 |
38 | 60,168 | 68,050 | 182,399 |
|
United States | Pfizer Inc. |
Others
|
34 | 26 | 0.765 | 46 | 37 | 0.804 | 17,201 | 4,816 | 0.280 |
39 | 61,380 | 69,451 | 186,955 |
|
United States | Pfizer Inc. |
Natural Sciences / Molecular Biology & Genetics
Genetics | Genomics | Mouse Models | Behavior | Rare Diseases | |
34 | 19 | 0.559 | 46 | 26 | 0.565 | 6,175 | 1,701 | 0.275 |
40 | 63,881 | 72,279 | 195,935 |
|
United States | Pfizer Inc. |
Others
|
33 | 22 | 0.667 | 56 | 37 | 0.661 | 4,837 | 1,701 | 0.352 |
Only in AD Scientific Index !!!!Subject Rankings, University Subject Rankings, Citiation Rankings, i10 Productivity Rankings, Country Rankings, Detailed analyses of universities |
||||||||||||||||
41 | 63,937 | 72,338 | 196,079 |
|
United States | Pfizer Inc. |
Natural Sciences / Molecular Biology & Genetics
Cell & Molecular Biology | Biochemistry | |
33 | 22 | 0.667 | 47 | 34 | 0.723 | 3,508 | 1,240 | 0.353 |
42 | 64,403 | 72,881 | 197,872 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
pharmacokinetics | clinical pharmacology | pharmacodynamics | |
33 | 19 | 0.576 | 64 | 34 | 0.531 | 4,393 | 1,292 | 0.294 |
43 | 64,656 | 73,158 | 198,627 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Immunology
Immunology | Pharmacology | Respiratory | |
33 | 18 | 0.545 | 46 | 29 | 0.630 | 5,567 | 1,030 | 0.185 |
44 | 65,647 | 74,262 | 201,866 |
|
United States | Pfizer Inc. |
Others
drug discovery | proteomics | |
32 | 29 | 0.906 | 39 | 37 | 0.949 | 7,410 | 4,545 | 0.613 |
45 | 67,207 | 76,053 | 207,828 |
|
United States | Pfizer Inc. |
Others
Computational Drug Discovery | |
32 | 22 | 0.688 | 40 | 33 | 0.825 | 4,634 | 2,205 | 0.476 |
46 | 68,336 | 77,337 | 212,025 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Medicinal chemistry | |
32 | 14 | 0.438 | 80 | 24 | 0.300 | 5,773 | 809 | 0.140 |
47 | 69,325 | 78,451 | 215,649 |
|
United States | Pfizer Inc. |
Medical and Health Sciences / Biostatistics
Biostatistics | clinical trials | adaptive designs | |
31 | 26 | 0.839 | 61 | 53 | 0.869 | 7,959 | 6,305 | 0.792 |
48 | 69,363 | 78,493 | 215,791 |
|
United States | Pfizer Inc. |
Natural Sciences / Chemical Sciences
Molecular Modeling | Computational Chemistry | Drug Design&Development | 3D Modeling/Animation | Scientific Illustration | |
31 | 26 | 0.839 | 56 | 52 | 0.929 | 6,130 | 3,440 | 0.561 |
49 | 71,512 | 80,952 | 224,173 |
|
United States | Pfizer Inc. |
Others
Drug Research and Development | |
31 | 17 | 0.548 | 58 | 25 | 0.431 | 4,105 | 1,136 | 0.277 |
50 | 74,068 | 83,857 | 233,682 |
|
United States | Pfizer Inc. |
Engineering & Technology / Computer Science
Clinical Trials | Data MiningFirst interest | Second interest | |
30 | 21 | 0.700 | 77 | 52 | 0.675 | 5,065 | 1,901 | 0.375 |